BRIACELL THERAP (BCTX) vs GridAI Technologies Corp. (GRDX)

BRIACELL THERAP and GridAI Technologies Corp. are both Biotechnology companies. BRIACELL THERAP and GridAI Technologies Corp. are of similar size ($32.8M and $31.8M). GridAI Technologies Corp. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.5×. Across the 10 metrics below, BRIACELL THERAP leads on 5 and GridAI Technologies Corp. on 5.

Valuation

Metric BCTX GRDX Biotechnology median
P/E 1.53 n/m 8.50
P/S n/m n/m 9.71
P/B 1.06 1.82 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 65.24% (140.61%) (33.15%)
Free cash flow yield (126.67%) (29.90%) (25.50%)

Profitability

Metric BCTX GRDX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (173.55%) (485.88%) (56.36%)
Return on assets (139.20%) (34.14%) (48.04%)
Return on invested capital (3,311.00%) (79.29%) 0.00%

Growth

Metric BCTX GRDX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (43.04%) 74.65% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX GRDX Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 7.07 0.16 4.72
Net debt to EBITDA 0.66 0.10 0.96

Dividend

Metric BCTX GRDX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCTX GRDX Biotechnology median
Market cap 32.76m 31.81m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack